Alzheimer Disease & Dementia
09.21.24
Copy Link
Like
In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker tests for Alzheimer disease, including factors influencing the selection of these tests and recommendations for physicians when communicating test results with their patients. In this episode, Dr. Schindler presents an overview of factors influencing the selection of cerebrospinal fluid, PET, and blood-based biomarker tests.
Sign up to receive alerts and updates from The Neurology Hub.
Thanks for subscribing
Do you have cases, images, or other information to share? The Neurology Hub welcomes submissions from clinicians and researchers at all levels.
Contribute Here